Polysaccharide/mesoporous silica nanoparticle-based drug delivery systems: A review
Mesoporous silica nanoparticles (MSNs) have been well-researched in the design and fabrication of advanced drug delivery systems (DDSs) due to their advantages such as good biocompatibility, large specific surface area and pore volume for drug loading, easily surface modification, adjusted size and...
Gespeichert in:
| Veröffentlicht in: | International journal of biological macromolecules 2021-12, Vol.193 (Pt A), p.457-473 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 473 |
|---|---|
| container_issue | Pt A |
| container_start_page | 457 |
| container_title | International journal of biological macromolecules |
| container_volume | 193 |
| creator | Kuang, Ying Zhai, Junjun Xiao, Qinjian Zhao, Si Li, Cao |
| description | Mesoporous silica nanoparticles (MSNs) have been well-researched in the design and fabrication of advanced drug delivery systems (DDSs) due to their advantages such as good biocompatibility, large specific surface area and pore volume for drug loading, easily surface modification, adjusted size and good thermal/chemical stability. For MSN-based DDSs, gate materials are also necessary. And natural polysaccharides, one kind of the most abundant natural resource, have been widely applied as the “gatekeepers” in MSN-based DDSs. Polysaccharides are cheap and rich in sources with good biocompatibility, and some of them have important biological functions. In this review article, polysaccharides including chitosan, hyaluronic acid, sodium alginate and dextran, et al. are briefly introduced. And the preparation processes and properties such as controlled drug release, cancer targeting and disease diagnosis of functional polysaccharide/MSN-based DDSs are discussed. |
| doi_str_mv | 10.1016/j.ijbiomac.2021.10.142 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2590130944</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0141813021022996</els_id><sourcerecordid>2590130944</sourcerecordid><originalsourceid>FETCH-LOGICAL-c368t-6475cf7d82f18a3a53cd6b394b38a3081224e2eaaab2ac741e3769f8551701f83</originalsourceid><addsrcrecordid>eNqFkEtPwzAQhC0EoqXwF6ocuaT1K4nDiariJVUCCThbjr0BV0ld7LQo_x6Xtlw5rXb0za5mEBoTPCGY5NPlxC4r61qlJxRTMtnpnJ6gIRFFmWKM2SkaYsJJKgjDA3QRwjKqeUbEORowXhDMCz5Ery-u6YPS-lN5a2DaQnBr590mJME2VqtkpVZurXxndQNppQKYxPjNR2KgsVvwfRL60EEbbpJZ4mFr4fsSndWqCXB1mCP0fn_3Nn9MF88PT_PZItUsF12a8yLTdWEErYlQTGVMm7xiJa9YXLEglHKgoJSqqNIFJ8CKvKxFlpECk1qwEbre311797WB0MnWBg1No1YQA0ialTiGLzmPaL5HtXcheKjl2ttW-V4SLHeFyqU8Fip3hf7qnEbj-PBjU7Vg_mzHBiNwuwcgJo3pvQzawkqDsR50J42z__34AWuFiuE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2590130944</pqid></control><display><type>article</type><title>Polysaccharide/mesoporous silica nanoparticle-based drug delivery systems: A review</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Kuang, Ying ; Zhai, Junjun ; Xiao, Qinjian ; Zhao, Si ; Li, Cao</creator><creatorcontrib>Kuang, Ying ; Zhai, Junjun ; Xiao, Qinjian ; Zhao, Si ; Li, Cao</creatorcontrib><description>Mesoporous silica nanoparticles (MSNs) have been well-researched in the design and fabrication of advanced drug delivery systems (DDSs) due to their advantages such as good biocompatibility, large specific surface area and pore volume for drug loading, easily surface modification, adjusted size and good thermal/chemical stability. For MSN-based DDSs, gate materials are also necessary. And natural polysaccharides, one kind of the most abundant natural resource, have been widely applied as the “gatekeepers” in MSN-based DDSs. Polysaccharides are cheap and rich in sources with good biocompatibility, and some of them have important biological functions. In this review article, polysaccharides including chitosan, hyaluronic acid, sodium alginate and dextran, et al. are briefly introduced. And the preparation processes and properties such as controlled drug release, cancer targeting and disease diagnosis of functional polysaccharide/MSN-based DDSs are discussed.</description><identifier>ISSN: 0141-8130</identifier><identifier>EISSN: 1879-0003</identifier><identifier>DOI: 10.1016/j.ijbiomac.2021.10.142</identifier><identifier>PMID: 34710474</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Delayed-Action Preparations ; Drug Carriers - pharmacology ; Drug delivery system ; Humans ; Mesoporous silica nanoparticle ; Nanoparticles - chemistry ; Neoplasms - drug therapy ; Polysaccharide ; Polysaccharides - pharmacology ; Silicon Dioxide - pharmacology</subject><ispartof>International journal of biological macromolecules, 2021-12, Vol.193 (Pt A), p.457-473</ispartof><rights>2021 Elsevier B.V.</rights><rights>Copyright © 2021 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c368t-6475cf7d82f18a3a53cd6b394b38a3081224e2eaaab2ac741e3769f8551701f83</citedby><cites>FETCH-LOGICAL-c368t-6475cf7d82f18a3a53cd6b394b38a3081224e2eaaab2ac741e3769f8551701f83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0141813021022996$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34710474$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kuang, Ying</creatorcontrib><creatorcontrib>Zhai, Junjun</creatorcontrib><creatorcontrib>Xiao, Qinjian</creatorcontrib><creatorcontrib>Zhao, Si</creatorcontrib><creatorcontrib>Li, Cao</creatorcontrib><title>Polysaccharide/mesoporous silica nanoparticle-based drug delivery systems: A review</title><title>International journal of biological macromolecules</title><addtitle>Int J Biol Macromol</addtitle><description>Mesoporous silica nanoparticles (MSNs) have been well-researched in the design and fabrication of advanced drug delivery systems (DDSs) due to their advantages such as good biocompatibility, large specific surface area and pore volume for drug loading, easily surface modification, adjusted size and good thermal/chemical stability. For MSN-based DDSs, gate materials are also necessary. And natural polysaccharides, one kind of the most abundant natural resource, have been widely applied as the “gatekeepers” in MSN-based DDSs. Polysaccharides are cheap and rich in sources with good biocompatibility, and some of them have important biological functions. In this review article, polysaccharides including chitosan, hyaluronic acid, sodium alginate and dextran, et al. are briefly introduced. And the preparation processes and properties such as controlled drug release, cancer targeting and disease diagnosis of functional polysaccharide/MSN-based DDSs are discussed.</description><subject>Delayed-Action Preparations</subject><subject>Drug Carriers - pharmacology</subject><subject>Drug delivery system</subject><subject>Humans</subject><subject>Mesoporous silica nanoparticle</subject><subject>Nanoparticles - chemistry</subject><subject>Neoplasms - drug therapy</subject><subject>Polysaccharide</subject><subject>Polysaccharides - pharmacology</subject><subject>Silicon Dioxide - pharmacology</subject><issn>0141-8130</issn><issn>1879-0003</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkEtPwzAQhC0EoqXwF6ocuaT1K4nDiariJVUCCThbjr0BV0ld7LQo_x6Xtlw5rXb0za5mEBoTPCGY5NPlxC4r61qlJxRTMtnpnJ6gIRFFmWKM2SkaYsJJKgjDA3QRwjKqeUbEORowXhDMCz5Ery-u6YPS-lN5a2DaQnBr590mJME2VqtkpVZurXxndQNppQKYxPjNR2KgsVvwfRL60EEbbpJZ4mFr4fsSndWqCXB1mCP0fn_3Nn9MF88PT_PZItUsF12a8yLTdWEErYlQTGVMm7xiJa9YXLEglHKgoJSqqNIFJ8CKvKxFlpECk1qwEbre311797WB0MnWBg1No1YQA0ialTiGLzmPaL5HtXcheKjl2ttW-V4SLHeFyqU8Fip3hf7qnEbj-PBjU7Vg_mzHBiNwuwcgJo3pvQzawkqDsR50J42z__34AWuFiuE</recordid><startdate>20211215</startdate><enddate>20211215</enddate><creator>Kuang, Ying</creator><creator>Zhai, Junjun</creator><creator>Xiao, Qinjian</creator><creator>Zhao, Si</creator><creator>Li, Cao</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20211215</creationdate><title>Polysaccharide/mesoporous silica nanoparticle-based drug delivery systems: A review</title><author>Kuang, Ying ; Zhai, Junjun ; Xiao, Qinjian ; Zhao, Si ; Li, Cao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c368t-6475cf7d82f18a3a53cd6b394b38a3081224e2eaaab2ac741e3769f8551701f83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Delayed-Action Preparations</topic><topic>Drug Carriers - pharmacology</topic><topic>Drug delivery system</topic><topic>Humans</topic><topic>Mesoporous silica nanoparticle</topic><topic>Nanoparticles - chemistry</topic><topic>Neoplasms - drug therapy</topic><topic>Polysaccharide</topic><topic>Polysaccharides - pharmacology</topic><topic>Silicon Dioxide - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kuang, Ying</creatorcontrib><creatorcontrib>Zhai, Junjun</creatorcontrib><creatorcontrib>Xiao, Qinjian</creatorcontrib><creatorcontrib>Zhao, Si</creatorcontrib><creatorcontrib>Li, Cao</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of biological macromolecules</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kuang, Ying</au><au>Zhai, Junjun</au><au>Xiao, Qinjian</au><au>Zhao, Si</au><au>Li, Cao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Polysaccharide/mesoporous silica nanoparticle-based drug delivery systems: A review</atitle><jtitle>International journal of biological macromolecules</jtitle><addtitle>Int J Biol Macromol</addtitle><date>2021-12-15</date><risdate>2021</risdate><volume>193</volume><issue>Pt A</issue><spage>457</spage><epage>473</epage><pages>457-473</pages><issn>0141-8130</issn><eissn>1879-0003</eissn><abstract>Mesoporous silica nanoparticles (MSNs) have been well-researched in the design and fabrication of advanced drug delivery systems (DDSs) due to their advantages such as good biocompatibility, large specific surface area and pore volume for drug loading, easily surface modification, adjusted size and good thermal/chemical stability. For MSN-based DDSs, gate materials are also necessary. And natural polysaccharides, one kind of the most abundant natural resource, have been widely applied as the “gatekeepers” in MSN-based DDSs. Polysaccharides are cheap and rich in sources with good biocompatibility, and some of them have important biological functions. In this review article, polysaccharides including chitosan, hyaluronic acid, sodium alginate and dextran, et al. are briefly introduced. And the preparation processes and properties such as controlled drug release, cancer targeting and disease diagnosis of functional polysaccharide/MSN-based DDSs are discussed.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>34710474</pmid><doi>10.1016/j.ijbiomac.2021.10.142</doi><tpages>17</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0141-8130 |
| ispartof | International journal of biological macromolecules, 2021-12, Vol.193 (Pt A), p.457-473 |
| issn | 0141-8130 1879-0003 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2590130944 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Delayed-Action Preparations Drug Carriers - pharmacology Drug delivery system Humans Mesoporous silica nanoparticle Nanoparticles - chemistry Neoplasms - drug therapy Polysaccharide Polysaccharides - pharmacology Silicon Dioxide - pharmacology |
| title | Polysaccharide/mesoporous silica nanoparticle-based drug delivery systems: A review |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T00%3A16%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Polysaccharide/mesoporous%20silica%20nanoparticle-based%20drug%20delivery%20systems:%20A%20review&rft.jtitle=International%20journal%20of%20biological%20macromolecules&rft.au=Kuang,%20Ying&rft.date=2021-12-15&rft.volume=193&rft.issue=Pt%20A&rft.spage=457&rft.epage=473&rft.pages=457-473&rft.issn=0141-8130&rft.eissn=1879-0003&rft_id=info:doi/10.1016/j.ijbiomac.2021.10.142&rft_dat=%3Cproquest_cross%3E2590130944%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2590130944&rft_id=info:pmid/34710474&rft_els_id=S0141813021022996&rfr_iscdi=true |